Need professional-grade analysis? Visit stockanalysis.com
$33.05M
15.59
N/A
N/A
Bioqual Inc (BIOQ) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $37.51.
Over the past year, BIOQ has traded between a low of $37.00 and a high of $50.00. The stock has lost 25.0% over this period. It is currently 25.0% below its 52-week high.
Bioqual Inc has a market capitalization of $33.05M, with a price-to-earnings ratio of 15.59.
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and tailored assay development services; and Biocontainment, imaging services, and animal model development; and IND-enabling services, such as toxicology studies, pharmacokinetic profiling, GLP services, and regulatory documentation services. Bioqual, Inc. was incorporated in 1981 and is based in Rockville, Maryland.
Side-by-side comparison against top Healthcare peers.